RX DM financials
A multi-period view of the public annual-account figures reported for RX DM, with comparable measures and links to available source documents.
Company overviewRegistry number
0722787085
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 29, 2026
Financial evidence
Latest movements for RX DM
2025 versus 2024
- Operating line
- €127,963
- EBITDA
- €127,963
- Total assets
- €189,746
- Equity
- €130,256
+15.2%
+15.2%
+7.1%
+7.9%
EBITDA margin +100% · Equity ratio +68.6%
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.